factually
Index/Organizations/TauRx Therapeutics

TauRx Therapeutics

Pharmaceutical company based in Singapore

Fact-Checks

3 results
Jan 18, 2026
Most Viewed

What randomized clinical trials are underway testing low‑dose methylene blue for Alzheimer’s disease and what are their endpoints?

Low‑dose methylene blue (and its reduced proprietary forms LMTM/HMTM) remains under active clinical investigation for Alzheimer’s disease (AD) in a small set of randomized trials that focus on short‑t...

Jan 27, 2026
Most Viewed

What dose ranges and formulations (hydromethylthionine vs methylene blue) have different safety and absorption profiles in human studies?

Two chemically related agents — classical (methylthioninium chloride, MTC) and a stabilized reduced derivative called hydromethylthionine (HMT; marketed as hydromethylthionine mesylate, HMTM or TRx023...

Jan 19, 2026

What were the design flaws and subgroup analyses in TauRx’s earlier LMTM Phase III trials?

TauRx’s earlier Phase III trials of LMTM (leuco‑methylthioninium/HMTM/LMTX) repeatedly failed their prespecified primary endpoints, but the company highlighted statistically significant effects in sma...